prnewswire.comTeva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology13 days ago
cnbc.comHere are Friday's biggest analyst calls: Tesla, Nvidia, Robinhood, Microsoft, Deere, Amazon, McDonald's & more23 days ago
benzinga.comTeva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 2030about 1 month ago
cnbc.comHere are Wednesday's biggest analyst calls: Nvidia, Apple, Broadcom, Microsoft, Teva, AutoZone, Vail & moreabout 1 month ago
cnbc.comInvestors should buy the dip on this pharma stock with 40% upside, Truist saysabout 1 month ago
cnbc.comHere are Monday's biggest analyst calls: Nvidia, Apple, Walmart, Amazon, Alphabet & moreabout 2 months ago
CashuTeva Pharmaceutical's Analyst Ratings Reveal Diverse Perspectives Amid Industry Challenges2 days ago
CashuTeva Pharmaceutical Partners with Fosun Pharma to Advance TEV-56278 Cancer Therapy Development10 days ago
CashuTeva Pharmaceutical Partners with Fosun Pharma for TEV-56278 Oncology Development Initiative12 days ago